The GZF1 Knockout HEK293T Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population derived from the widely used human embryonic kidney HEK293T cell line. This product provides a loss-of-function model for the GZF1 gene, enabling mechanistic studies of its role in transcriptional repression and signal transduction. The polyclonal format ensures representation of genetic heterogeneity while maintaining robust knockout at the population level, without clonal selection artifacts. These cells are supplied as a ready-to-use research tool for functional genomics and pathway interrogation.
HEK293T cells are a derivative of HEK293 cells that stably express the SV40 large T antigen, which enhances episomal replication and significantly increases protein expression. This host cell line is a cornerstone of biomedical research, extensively employed for viral production, transient transfection, and biochemical assays. Its epithelial origin, ease of culture, and high transfectability make it an ideal background for generating knockout models and studying signaling pathways in a human cellular context.
GZF1 encodes a zinc finger protein that functions as a transcriptional repressor by binding to GC-rich sequences in gene promoters. It plays a critical regulatory role in Nodal and TGF-beta signaling pathways, where it directly represses target genes such as NODAL and TDGF1. Upon ligand stimulation by GDNF, TGF-beta, or BMP4, GZF1-mediated repression is relieved through interactions with SMAD2 and SMAD3 transcription factors. In wild-type cells, GZF1 restrains NODAL and TDGF1 expression, thereby limiting downstream activation of the ACVR1B?CSMAD2/3?CSMAD4?CFOXH1 signaling axis. Disruption of GZF1 in these polyclonal knockout cells leads to derepression of NODAL and TDGF1, resulting in elevated SMAD2/3 phosphorylation and enhanced transcription of cell cycle regulators such as CCND1 and CDKN1A.
In the HEK293T background, GZF1 knockout provides a powerful model to dissect its tumor suppressor-like functions and contributions to developmental signaling. The loss of GZF1 disrupts the balance between proliferation and cell cycle arrest, mimicking aspects of hematological disorders including myelodysplastic syndrome and acute myeloid leukemia, as well as solid tumors like glioma. Furthermore, the enhanced Nodal signaling in these cells facilitates investigation of GZF1??s role in congenital heart defects, where Nodal pathway dysregulation is implicated. The HEK293T system allows for controlled manipulation of upstream regulators and parallel assessment of downstream transcriptional changes.
This knockout cell product is suitable for a wide range of experimental applications, including RT-qPCR and Western blot analysis to quantify changes in target gene expression and SMAD phosphorylation status. Luciferase reporter assays can be employed to monitor Nodal response activity, while proliferation assays reveal functional consequences of GZF1 loss. Global transcriptomic profiling via RNA-seq and chromatin occupancy studies by ChIP-qPCR further elucidate GZF1??s regulatory network. Applications extend to screening small molecules or cytokines that modulate the Nodal/TGF-beta pathway, providing a platform for drug sensitivity testing and investigation of pathway crosstalk. For additional technical details, please contact Ascent Research.
